Price (GBX)
3,214.00 1.26% (40.00)
DPHORD 1P
Track 1 instrument
Open / Last close
3,180.00 / 3,214.00
High / Low
3,242.00 / 3,166.00
Bid / Offer
3,206.00 / 3,212.00
Turnover
£7,256,587.68
Special Condition: XD
Trading Status: End of Post Close
As at 25.11.20 17:19:59 - All data delayed at least 15 minutes

DECHRA PHARMACEUTICALS PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
DPHORD 1P3,214.00
GBX
1.26%Equity-

Price information

What's this?
Open price
3,180.00
Previous close price / date
3,214.00 / 25 November 2020
Volume
441,115
Turnover (on book)
£7,256,587.68
52 week range
2,168.00 / 3,574.00
YTD return
9.39
1 year return
14.79

Instrument information

What's this?
Market
Main Market
Instrument market cap (£m)
3,430.90
Earnings per share
0.33
Issue date
02 December 2005
ISIN
GB0009633180
SEDOL
0963318
Market identifier code (MIC)
XLON
Country of share register
GB
Market segment
STMM
Trading service
SETS
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
25.11.20 17:06:55 3,212.16 GBX 1,058 33,984.66 Off-Book TNCP XOFF
25.11.20 16:36:47 3,220.82 GBX 56,392 1,816,285.38 Off-Book BENC TNCP SINT
25.11.20 16:36:26 3,214.00 GBX 218 7,006.52 AT - XLON
25.11.20 16:36:26 3,214.00 GBX 193 6,203.02 AT ALGO XLON
25.11.20 16:36:26 3,214.00 GBX 180 5,785.20 AT - XLON

Upcoming Events

from DECHRA PHARMACEUTICALS PLC
Interim results - period to 31 December 2020
February 22nd 2021, 7:00:00am

Duration: + Add to my Calendar

Equity Research

from DECHRA PHARMACEUTICALS PLC
Morning Song

Dechra Pharmaceuticals (DPH LN) In line trading update & entry to Brazil | Futura Medical (FUM LN) Equity capital raise for MED2002 development | Urban Logistics REIT (SHED LN) Strong NAV performance, and total returns | Zytronic (ZYT LN) Year end update – revenue in line, lower than expected margin ...

View report
Morning Song

Bagir Group (BAGR LN) Posting of circular and notice of EGM - proposed strategic partnership | Dechra Pharmaceuticals (DPH LN) Sterling progress once again, but one or two clouds on the horizon | Future (FUTR LN) A great summer | Microsaic Systems (MSYS LN) Progressing to plan | Murgitroyd Group (MU ...

View report
Morning Song

Craneware (CRW LN) Trading update & contract win | Dechra Pharmaceuticals (DPH LN) In line FY trading update | Eckoh (ECK LN) Contract win through Capita partnership | Miton Group (MGR LN) Strong H1 net inflows, upgrading FY18e EPS by 11% | MySale Group (MYSL LN) Another record year & more potential ...

View report
Morning Song

Dechra Pharmaceuticals (DPH LN) Interims contain no surprises, AST/Le Vet acq now complete | Dialight (DIA LN) Are we nearly there yet? | Eckoh (ECK LN) US secure payments win and new US partnership | GlobalData (DATA LN) Results driven by strong trading | Photo-Me International (PHTM LN) Appointmen ...

View report
Morning Song

Dechra Pharmaceuticals (DPH LN) Acquisition of Le Vet to drive next leg of growth | Low & Bonar (LWB LN) Significant change | PCI-PAL (PCIP LN) Secure payments offers exciting growth potential | Sigma Capital Group (SGM LN) The PRS REIT launches placing programme to raise up to c.£250m

View report

Latest reports

from DECHRA PHARMACEUTICALS PLC
2020 Annual Report
link

Contacts

from DECHRA PHARMACEUTICALS PLC
CEO
Ian Page
atDECHRA PHARMACEUTICALS PLC
+44 (0) 1606 814 730
corporate.enquiries@dechra.com
CFO
Paul Sandland
atDECHRA PHARMACEUTICALS PLC
+44 (0) 1606 814730
corporate.enquiries@dechra.com
Company Secretary
Melanie Hall
atDECHRA PHARMACEUTICALS PLC
+44 (0) 1606 814 730
corporate.enquiries@dechra.com
Issuer presentations live and on demand
Watch on Spark Live